0 Комментарии
0 Поделились
811 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
PCR Molecular Diagnostics Market Report Scope: Comprehensive Study of Market Trends and ForecastThe global PCR Molecular Diagnostics Market 2031 is witnessing steady expansion as healthcare systems increasingly adopt advanced genetic testing technologies for early, accurate, and rapid disease detection across infectious diseases, oncology, and genetic disorders. PCR (Polymerase Chain Reaction) remains a core molecular diagnostic technique due to its high sensitivity, precision, and...0 Комментарии 0 Поделились 531 Просмотры 0 предпросмотр
-
Digital PCR and Real-Time PCR Market 2031: Size, Share, Strategy, and Key Players AnalysisThe Digital PCR and Real-Time PCR Market is witnessing strong global expansion, driven by the increasing need for accurate, rapid, and high-throughput molecular diagnostic technologies. These solutions are widely utilized across clinical diagnostics, life sciences research, oncology, and infectious disease detection. With the growing emphasis on precision medicine and early disease diagnosis,...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Global Hepatitis B & C Diagnostics Market Insights & Growth Trends | CAGR 6.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global Hepatitis B and C Diagnostics market was valued at USD 3.8 billion in 2024 and is projected to reach USD 5.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025-2031. Hepatitis B diagnostic tests analyze blood samples for HBV antigens/antibodies (HBsAg, anti-HBc,...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Hepatitis B & C Diagnostics Market Insights & Growth Trends | CAGR 6.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global Hepatitis B and C Diagnostics market was valued at USD 3.8 billion in 2024 and is projected to reach USD 5.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025-2031. Hepatitis B diagnostic tests analyze blood samples for HBV antigens/antibodies (HBsAg, anti-HBc,...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр